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Abstract
Background: Alternative splicing is a major mechanism of generating protein diversity in higher
eukaryotes. Although at least half, and probably more, of mammalian genes are alternatively spliced,
it was not clear, whether the frequency of alternative splicing is the same in different functional
categories. The problem is obscured by uneven coverage of genes by ESTs and a large number of
artifacts in the EST data.
Results: We have developed a method that generates possible mRNA isoforms for human genes
contained in the EDAS database, taking into account the effects of nonsense-mediated decay and
translation initiation rules, and a procedure for offsetting the effects of uneven EST coverage. Then
we computed the number of mRNA isoforms for genes from different functional categories. Genes
encoding ribosomal proteins and genes in the category "Small GTPase-mediated signal
transduction" tend to have fewer isoforms than the average, whereas the genes in the category
"DNA replication and chromosome cycle" have more isoforms than the average. Genes encoding
proteins involved in protein-protein interactions tend to be alternatively spliced more often than
genes encoding non-interacting proteins, although there is no significant difference in the number
of isoforms of alternatively spliced genes.
Conclusion: Filtering for functional isoforms satisfying biological constraints and accountung for
uneven EST coverage allowed us to describe differences in alternative splicing of genes from
different functional categories. The observations seem to be consistent with expectations based on
current biological knowledge: less isoforms for ribosomal and signal transduction proteins, and
more alternative splicing of interacting and cell cycle proteins.
Background
The current estimates of the prevalence of alternative
splicing in the human genome fall into the interval 35–
60% [1-7], whereas the estimated number of human pro-
tein-coding genes has decreased from more than 100
thousand [8] through 30–35 thousand [3,9,10] to 20–25
thousand [11,12]. Thus alternative splicing emerges as a
major mechanism of generating protein diversity. Contin-
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uing sequencing of ESTs, whose number currently
approaches 4 million, uncovers rare, tissue- and stage-spe-
cific isoforms. On the other hand, a considerable number
of ESTs seem to arise from experimental artifacts (genome
contamination, unspliced transcripts, computational
errors leading to mis-alignment and clustering ESTs from
paralogous genes, etc.) or errors of the cellular splicing
machinery itself (so-called aberrant splicing). The latter
might be a relatively frequent event, as there exists a spe-
cial mechanism for surveillance of splicing errors, leading
to elimination of aberrant mRNA isoforms by nonsense-
mediated decay [13].
The algorithms for construction and enumeration of full-
length isoforms should take into account as many sources
of errors as possible. In early studies EST contigs were con-
structed as consensus exon sequences so that each exon
was used only once. This precluded combinatorial explo-
sion, but led to generation of short single-exon contigs,
and besides did not allow for enumeration of isoforms.
The use of contigs for estimation of the number of iso-
forms [14] leads to estimates that depend on EST coverage
[15]. Recent algorithms construct splicing graph whose
vertices correspond to sites and edges to sequence frag-
ments in such a way that each path in this graph corre-
sponds to a possible isoform [16-18]. Here we apply the
IsoformCounter algorithm that constructs the splicing
graph aligned to the genomic sequence and computes the
number of possible protein isoforms. The latter procedure
employs coverage-dependent thresholds for filtering arti-
facts.
We used IsoformCounter to compute the number of iso-
forms of alternatively spliced genes from the EDAS data-
base [19] for different functional classes of proteins from
GO [20]. We estimated the probability of spliceosome
error (1.2%) and suggested a simple probabilistic model
for filtering exons and introns obtained by EST-genome
spliced alignment. As a result we have obtained a robust
method for enumeration of protein isoforms independent
of EST coverage. We observed that the fraction of genes
with less alternative splicing (one or two protein isoforms
per gene) is higher in "Small GTPase-mediated signal
transduction" and "Ribosome" classes, and lower in the
"DNA replication and chromosome cycle" class, com-
pared to the average distribution. We also analyzed the
correlation between alternative splicing and protein-pro-
tein interactions and demonstrated that interacting pro-
teins are more likely to be encoded by alternatively spliced
genes.
Results
Algorithm for counting alternatively spliced isoforms
The following terms will be used. Exons and introns are
genome fragments that correspond to exons and introns
respectively in spliced alignment of some EST, mRNA, or
protein with genomic DNA. Initial and terminal exons
correspond respectively to first and last exons in spliced
alignment. Support of an exon is the number of clone
libraries containing ESTs whose spliced alignments con-
tain exactly this exon; specific cases are spliced alignments
with mRNA and proteins that generate exons of mRNA
and protein support respectively. Protein-supported exons
are ascribed the reading frame derived from protein
spliced alignment, whereas EST- and mRNA-supported
exons are considered as triples with the same splicing sites
and all possible reading frames.
For each gene (genomic fragment and corresponding
ESTs, mRNAs and proteins) the algorithm constructs the
splicing graph. Each splicing site corresponds to three verti-
ces of this graph (for three possible positions relative to
the reading frame), and its edges are exons and introns.
The reading frames of vertices and corresponding edges
are consistent. Thus each path through this graph corre-
sponds to a candidate mRNA isoform. There is also a spe-
cial type of vertices, start and stop codons, that open and
close a reading frame respectively. A protein isoform is a
path starting at a start codon or 5'-boundary of an initial
exon and ending at a stop codon, with an additional con-
dition that initial and terminal exons are supported by at
least two clone libraries.
The IsoformCounter algorithm filters isoforms (paths)
unlikely to be expressed as a functional protein. The filters
are listed below.
Representation of start and stop codons in the splicing graph Figure 1
Representation of start and stop codons in the splic-
ing graph. Rectangles: exons. Angle lines: introns. Circles: 
stop codons. Arrows: start codons. Filled arows: start 
codons generated by alignment with proteins. Crossed 
arrows: start codons in-frame with an upstream acceptor site 
or a start codon. The following situations are considered and 
marked on the scheme:. (1) In each exon, for each possible 
reading frame, a stop codon closing this reading frame gener-
ates a stop-vertex. (2) If an exon contains a start codon pre-
ceded by a stop codon in the same reading frame, a start-
vertex is generated. If a start codon coincides with the begin-
ning of a protein-genome alignment, it generates a start-vertex 
irrespective of upstream stop codons (gray exon). In the lat-
ter case, no additional filters are applied (see the text). (3) 
Any start-vertex that is in-frame with an upstream acceptor 
site or a start codon is removed (crossed arrow).BMC Bioinformatics 2005, 6:266 http://www.biomedcentral.com/1471-2105/6/266
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(1) Start codons (Fig. 1)
An ATG codon generates a vertex only if it is confirmed by
spliced alignment with a protein or if it is preceded in an
exon by a stop codon in the same reading frame. Thus a
protein isoform starts with the leftmost methionine in a
given reading frame or by a methionine supported by a
protein spliced alignment. To account for a possibility of
insufficient coverage of a gene 5'-region, we also allow a
protein isoform to start at a 5'-end of an initial exon, if this
isoform does not contain in-frame protein-supported
methionine codon.
(2) Initiation of translation (Fig. 2)
Translation initiation of most eukaryotic mRNAs uses the
so-called linear scanning mechanism: 40S ribosomal sub-
unit binds the cap structure at the 5'-terminus of the
mRNA and slides to the proximal ATG codon, where it ini-
tiates translation, if the codon is in a favorable context
[25]. Stable hairpins and upstream ATG codons decrease
the efficiency of the linear scanning. A minor fraction of
mRNAs (2–8%) contain internal sites of translation initi-
ation [26,27]. To emulate this mechanism, Isofom-
Counter considers only isoforms with at most two
upstream ATGs, unless the start codon is supported by a
protein.
(3) Short protein isoforms
We assume that alternative splicing may eliminate up to
50% of the average protein length, that is, the average
length of proteins from RefSeq corresponding to the given
gene. If the gene does not have RefSeq entries, the average
length of corresponding proteins in EDAS is used. Further,
no proteins shorter than 33 amino acids were considered.
(4) Consistency with proteins
We required that an isoform had at least one amino acid
overlapping with a known protein encoded by the gene.
This filter is sufficient to remove long open reading frames
in 5'-untranslated regions. On the other hand, selecting a
stricter threshold would lead to the loss of some known
isoforms. Further, we require that there are no conflicts
between reading frames generated by intersections with
proteins.
(5) Premature termination of translation (Fig. 2)
It is known that transcripts containing premature stop-
codons due, in particular, to spliceosomal errors, are
degraded by a specific mechanism of nonsense-mediated
decay (NMD) [13]. As we have no criterion for distin-
guishing between functional and aberrant alternative
splicing, we implemented a filter imitating the NMD
action, requiring that the last exon-exon junction in an
isoform were at most 55 nucleotides downstream its stop-
codon. As above, this filter was not applied to protein-
supported isoforms.
Counting protein isoforms
To compute the number of protein isoforms, Isoform-
Counter finds the number of all paths in the splicing
graph and subtracts the number of paths not consistent
with any known protein, see filter (4). The former value is
computed in linear time (respective the number of edges)
by dynamic programming. To compute the latter value,
IsoformCounter constructs a subset A of acceptor sites of
protein-supported exons and exons that overlap the
former in consistent reading frame. Then the complement
set A* of acceptor sites is determined, and the number of
paths coming through A* (and not through any site from
A) is calculated by dynamic programming. By definition,
these paths are not consistent with any known protein.
Computing the numer of alternative regions in the longest protein 
isoform
Constitutive regions are exon fragments whose genome
projections never overlap with introns or intergenic spac-
ers. The procedures described above allow for segmenta-
tion of the longest protein isoform into constitutive and
alternative regions so that only valid isoforms that have
passed all filters are taken into account.
Normalization procedure for EST-derived exons and introns
The following model was considered. Let α be the proba-
bility of splicing error (loss of a site), and let ξ be the
expression level (average number of gene transcripts per
cell). We assume that ξ = f(N), where N is the observed
number of ESTs. Let P(N) be the probability that the cell
contains at least one aberrantly spliced transcript, P = 1 -
(1 - α)ξ. Then the probability that the error occurred in an
interval supported by k clone libraries is Pk ≤ β, where β
denotes the significance level, that is, the probability with
which we accept a splicing error. Solving this inequality
with respect to k, we obtain k(ξ) ≥ ln(β) / ln(1 - (1 - α)ξ).
Filters on translation initiation for start-vertices and non- sense-mediated decay for stop-vertices Figure 2
Filters on translation initiation for start-vertices and 
nonsense-mediated decay for stop-vertices. Circles: 
stop-vertices. Arrows: start-vertices. (1) Filters are not 
applied to vertices supported by protein-genome alignment 
(filled symbols). (2) Translation initiation filter: start-vertices 
preceded by at least two ATG codons in at least one path 
are removed. (3) Nonsense-mediated decay filter: stop-verti-
ces for which the distance to the nearest donor site exceeds 
55 nucleotides are removed.BMC Bioinformatics 2005, 6:266 http://www.biomedcentral.com/1471-2105/6/266
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We estimate the expression level as ξ = N/5. To estimate
the probability of a splicing error, we considered losses of
one or two sites corresponding to a protein-supported
intron. The number of such events Noverlap can be esti-
mated as the number of ESTs which overlap the intron
sites and are not spliced at these sites. This is an overesti-
mate, as real alternative splicing events also are counted.
Further, let Nsplice be the number of ESTs whose spliced
alignment contain protein-supported introns. The proba-
bility of the spliceosome error was estimated as α = Nover-
lap/(Noverlap+Nsplice) computed as 0.012. Note that one EST
could be counted both for Noverlap and Nsplice, so the above
value could be an underestimate. Finally, we used the fol-
lowing threshold on the number of clone libraries
required to accept an exon (dependent on the EST cover-
age of the gene): k( N) = [- 1/ln(1-0,988N/5)]. Exons and
introns confirmed by alignment with mRNA or protein
are always accepted.
The restricted set of protein isoforms
For each gene in EDAS we constructed the restricted set of
protein isoforms that are amino acid sequences are avail-
able at [37]. Define isoform support as the minimum sup-
port of exons and introns forming the isoform. For each
edge in the splicing graph (exon or intron) we construct
the longest isoform passing through the edge, whose sup-
port is not less than the edge support. At each level of sup-
port, the restricted set consists of such longest isoforms for
all edges of the given support.
Analysis of alternative splicing in functional categories of 
genes
When IsoformCounter was applied to all genes from
EDAS, in 431 cases (4%) no isoforms were found. This
could happen in one of there cases. (1) Protein-DNA
spliced alignment does not end at stop codon, and there
is no downstream terminal exon where the induced read-
ing frame contains a stop codon. (2) Protein-DNA spliced
alignment does not start at methionine, and there is no
upstream exon where the induced open reading frame
contains an ATG codon preceded by a stop codon (see fil-
ter 1 in Methods). (3) Protein-DNA spliced alignment
does not start at methionine and the candidate ATG found
by the algorithm is eliminated by the filter on translation
initiation (filter 2), or the alignment does not end at a
stop codon, and the candidate stop codon is eliminated
by the filter on premature termination of translation
(nonsense-mediated decay, filter 5). The first and second
cases are due to incomplete proteins where no candidate
start or stop codon could be assigned. In the third case a
start or stop codon could be assigned based on spliced
alignment with incomplete protein and ESTs, but the
obtained reading frame was eliminated by the filters. It
may happen if the gene has an internal translation initia-
tion site or a special mechanism to keep the isoform from
the NMD degradation. In both cases algorithm needs an
alignment with a complete protein. All these genes were
ignored.
The obtained distribution of the isoform numbers is
shown in Fig. 3 (blue columns). As it is known that the
predicted number of isoforms may depend on the EST
coverage, we analyzed the dependence between the EST
coverage of a gene and the number of isoforms (Fig. 4).
The blue plot, corresponding to the initial (raw) data
demonstrates that genes with high EST coverage (>900
Correlation between the isoform number and EST coverage Figure 4
Correlation between the isoform number and EST 
coverage. Blue: raw data (all ESTs). Red: normalized data 
(coverage-dependent filter on the number of clone libraries 
supporting exons, see Results). Each dot represents the aver-
age EST coverage for genes with the given number of iso-
forms. The peak in the normalized plot corresponds to the 
gene "eukaryotic translation elongation factor 1 alpha 1", rep-
resented by 18841 EST.
Blue columns: raw data Figure 3
Blue columns: raw data. Red columns: normalized data (see 
Results). The difference between histograms before and after 
normalization is weak, because the fraction of highly 
expressed genes (>400 ESTs) is small (approximately 4%).
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ESTs per gene) have a large number of isoforms (fall in the
tail of the distribution). In particular, this tail contains
many genes of ribosomal proteins (Fig. 5), which seems to
be an artifact. Indeed, it is highly likely that the high
expression level of a gene leads to appearance of relatively
rare aberrant isoforms that are not seen for weakly
expressed genes.
Thus we believe that the threshold level of EST support for
exons and introns should depend on the EST coverage of
a gene, so that weakly and highly expressed genes could be
comparable. Red columns in Fig. 3 show the number of
isoforms with this more stringent threshold. The distribu-
tions with raw and normalized data do not differ much,
but comparison of two plots in Fig. 4 shows that normal-
ization removes the dependence between EST coverage
and isoform number. One functional category strongly
affected by the normalization procedure is "ribosome".
Further we consider results obtained after normalization.
Most genes (91%) have a relatively small number of iso-
forms (1 through 15). The number of genes with an even
number of isoforms is higher than the number of genes
with odd number of isoforms. Indeed, the algorithm
assumes independence of individual elementary alterna-
tives, and thus the number of paths between two alterna-
tives is roughly the product of the number of variants.
Moreover, most local alternatives preserve the reading
frame. Thus, to have an even number of alternatives, it is
sufficient to have a frame-preserving local alternative with
two variants (e.g. a short cassette exon). 23% of genes had
only one functional isoform.
Fig. 5 shows the distribution of the number of alternative
and constitutive regions in the longest isoform. The frac-
tion of genes not containing constitutive fragments at all
is ~1%, which shows that the applied filters remove a con-
siderable fraction of aberrant events. Without these filters
most genes would contain only alternative regions. The
fraction of constitutive genes represented in Fig. 6 is 24%,
which is higher than the above estimate. It is caused by the
fact that introns not overlapping with the longest isoform
are not taken into account. The average number of all
(alternative and constitutive) fragments per gene is 3.7.
We considered the link between protein function and the
isoform number. The following functional categories
from GO were considered: "Small GTPase-mediated sig-
nal transduction" (145 genes), "Catabolism" (512 genes),
"DNA replication and chromosome cycle" (99 genes),
"Ribosome" (123 genes). Significant differences from the
distribution for all genes (p = 0.003 according to the
Mann-Whitney U test) were observed for "Ribosome" and
"Small GTPase-mediated signal transduction" categories.
Distribution of the isoform number in GO functional clusters Figure 7
Distribution of the isoform number in GO functional clus-
ters.
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Influence of normalization on the isoform number of pro-
teins from the "Ribosome" GO category. Color code as in 
Fig. 1.
Number of constitutive (blue) and alternative (red) regions in  the longest isoform Figure 6
Number of constitutive (blue) and alternative (red) 
regions in the longest isoform. The fraction of com-
pletely alternative genes is ~1%.BMC Bioinformatics 2005, 6:266 http://www.biomedcentral.com/1471-2105/6/266
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Both of them contain fewer than expected genes with a
large number of isoforms. In particular, there are 46%
constititutive genes in "Ribosome", although to very high
EST coverage this is observable only after normalization
(Fig. 5). Genes from the "DNA replication and chromo-
some cycle" have more isoforms that the average (p = 0.07
according to the Mann-Whitney U test). In particular,
there is a higher fraction of genes with two or more iso-
forms. The distribution of the isoform number for genes
from these categories is shown in Fig. 7.
Of 452 human interaction pairs in the MPPI database,
332 pairs were heterogeneous and different (excluding
protein contacts with itself and pairs that differ only by
the protein order). LocusLink information was available
for 312 of these pairs, containing 386 proteins. Of these
proteins, 262 are encoded by genes from EDAS, and pairs
with both members present in EDAS form 198 interacting
pairs.
No correlation was observed between the number of con-
tacts for a given protein and the number of isoforms or
alternative regions (data not shown). However, the prob-
ability to be alternatively spliced was higher for genes
encoding proteins participating in at least one protein-
protein interaction (Table 1). This observation was signif-
Table 1: Correlation between alternative splicing (AS) and protein-protein interactions (PPI). Expected numbers under independency 
assumption are given in parentheses. "EST-N" denotes isoforms with each exon supported by ESTs from at least N clone libraries.
protein data, χ2 = 11.17 No PPI At least one PPI TOTAL
No AS 5434 (5408) 122 (= 83% of 148) 5556
At least two AS-isoforms 3692 (3718) 127 (= 125% of 101) 3819
TOTAL 9126 249 9375
mRNA data, χ2 = 9.05 No PPI At least one PPI TOTAL
No AS 4879 (4856) 107 (= 82% of 130) 4986
At least two AS-isoforms 4360 (4383) 141 (= 120% of 118) 4501
TOTAL 9239 248 9487
EST-5 data, χ2 = 6.57 No PPI At least one PPI TOTAL
No AS 4463 (4443) 99 (= 83% of 119) 4562
At least two AS-isoforms 4804 (4324) 149 (= 115% of 129) 4953
TOTAL 9267 248 9515
EST-3 data, χ2 = 7.79 No PPI At least one PPI TOTAL
No AS 4001 (3979) 85 (= 80% of 107) 4086
At least two AS-isoforms 5302 (5324) 164 (= 115% of 142) 5466
TOTAL 9303 249 9552
EST-2 data, χ2 = 7.57 No PPI At least one PPI TOTAL
No AS 3299 (3278) 68 (= 77% of 89) 3367
At least two AS-isoforms 6063 (6084) 185 (= 113% of 164) 6248
TOTAL 9362 253 9615
normalized data, χ2 = 7.23 No PPI At least one PPI TOTAL
No AS 2275 (2257) 42 (= 70% of 60) 2317
At least two AS-isoforms 7066 (7084) 206 (= 110% of 188) 7272
TOTAL 9341 248 9589BMC Bioinformatics 2005, 6:266 http://www.biomedcentral.com/1471-2105/6/266
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icant for alternative splicing with all considered levels of
support (only proteins, proteins and mRNA, ESTs from
different number of clone libraries, ESTs with normalized
threshold) at the level <0.1–1% (the highest χ2 = 11.2 for
protein-supported alternatives, χ2 from 6.5 through 7.8
for EST-supported alternatives), although the difference
between observed and expected numbers is not large (17–
30% deficit of constitutive and 10–25% excess of alterna-
tively spliced genes among those encoding interacting
proteins). No significant correlations were observed for
larger, but noisier non-curated protein-protein interaction
datasets DIP and OPHID (data not shown).
Discussion and conclusion
IsoformCounter is a system of filters aiming at distin-
guishing functional isoforms from non-functional ones.
Unlike other programs for isoform generation [18,28] it
assumes independence of variants selected at elementary
alternatives.
The prevalence of genes with a relatively small number of
isoforms agrees with the observation of [29], where all
genes had less than 18 isoforms. On the other hand, the
prevalence of genes with the even number of isoforms not
observed in [29], where the minimal number of isoforms
required to explain all local alternatives was computed, as
opposed to all isoforms. The fact that 73–77% genes had
more than one isoform also is consistent with previous
estimates: the fraction of single-exon human genes is 20%
[30], and, as the latter are not covered by EDAS, the frac-
tion of alternatively spliced genes is approximately 60%
(75% of 80%) [14,31].
It has been reported that alternative splicing tends to affect
genes involved in signal transduction [31,32], although
no estimates on the significance of these findings was
done. We have also expected that there would be consid-
erable differences between such GO categories as "Metab-
olism" and "Signal transduction". However, this was not
observed, probably because these categories are too large
and contain many genes with diverse functions and prop-
erties. Still, we observed significantly lower number of iso-
forms for genes from the "Small GTPase-mediated signal
transduction" (compared to the distribution for all genes)
The correlation between alternative splicing of genes and
protein-protein interactions of encoded proteins was
somewhat unexpected, especially given previously
described lack of correlation between alternative and con-
tacting regions [33]. Further, although it has been
reported that alternative splicing often targets domains
involved in protein-protein interactions [34,35], there
was no increase in the rate of alternative splicing of such
domains.
The effect observed here was not particularly strong (~20–
25%), but still statistically significant, and was independ-
ent from the support level of alternatively spliced iso-
forms. On the other hand, the result crucially depended
on the reliability of protein-protein interaction data: no
correlation was observed for non-curated, large-scale
experimental (DIP) or inferred (OPHID) data.
Methods
The data about alternative splicing of human genes were
taken from the EDAS database [19,36]. EDAS contains
information about 9986 human genes (9914 with
LocusLink identifiers) of which 8324 (83%) show at least
some evidence of alternative splicing. The criteria for
inclusion of a gene into EDAS were as follows: at least one
linked protein sequence, at least one intron in the coding
region, and at least 25 ESTs.
The data about protein-protein interactions (PPI) were
taken from the manually curated MPPI database [21,39]
containing 452 pairs of interacting human proteins. We
also considered two PPI datasets, non-curated database of
PPI interactions from large-scale experiments (DIP) [22]
and predicted PPI (OPHID) [23]. Functional categories of
genes were taken from GeneOnthology [20,40].
Spliced alignments were constructed by Pro-Frame [24]
(protein-DNA) and Pro-EST [1] (mRNA-DNA and EST-
DNA).
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